Trials using children as subjects are much more problematic from an informed consent perspective than trials on competent adults, although the ‘therapeutic misconception’ is a central concern in both. The role of famous experiments and the use of one individual's experience to designate and justify a whole category of research have always threatened to undermine the validity of informed consent to research by making it seem to be a validated therapy. In research, the unintended consequence of ‘naming’ based on goals (‘cure’) or specific individuals (like the Mississippi Baby) tends to subvert informed consent when the famous case is a ‘success’, and to prematurely end a line of research if the named subject dies. Names, including the Mississippi Baby, Barney Clark, Baby Fae and even Martin Delaney, are more suggestive of fantasy than science. The word ‘cure’ should not be used in obtaining consent for HIV ‘cure trials’, and names of people involved in past experiments should be avoided in the informed consent process. These two modest proposals should reduce the risks of the therapeutic misconception in ‘cure research’.
- Informed Consent
- Research Ethics
- HIV Infection and AIDS
- Research on Special Populations
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- An activist's argument that participant values should guide risk–benefit ratio calculations in HIV cure research
- Could cancer research hold the key to a cure for HIV?
- The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
- Why cure, why now?
- When to start paediatric testing of the adult HIV cure research agenda?
- Uterus transplantation: ethical and regulatory challenges
- Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?
- Informed consent to HIV cure research
- How to keep high-risk studies ethical: classifying candidate solutions
- Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception